AlphAIAlphAI — Financial news for AI agents
stocktitan.netNOV 22 min read$CLX

Clorox sales rose 33%, but the share left after product costs fell to 40.4%

Clorox reported a 33% sales increase in Q1 FY2027, driven by the GOJO acquisition and organic growth. Gross margin fell to 40.4% due to higher costs. EPS rose 114% to $0.65. The company maintained its sales outlook but adjusted gross margin expectations downward to 41.5% due to inflation. CEO Linda Rendle cited progress on strategic priorities and cost savings.

Original reporting
stocktitan.net
Published Nov 2, 2026, 9:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 9:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$CLX
Neutral
high confidence
Mentioned
$CLX
Relevance
9/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CLXNeutralHigh
01

Why it matters

The earnings beat on sales is offset by lower margins, creating a nuanced market reaction.

02

Market read

First‑time earnings release with material numbers for a large‑cap consumer staple, offering actionable trading insight.

03

What to watch

Integration costs of GOJO acquisition and inventory step‑up may continue to impact earnings.

Relevance 9/10Novelty 9/10Timing: pre‑market today

Background

Clorox's FY2027 Q1 press release details revenue, margin, and guidance after integrating GOJO.

Company-level read

Ticker impact

$CLXNeutralHigh confidence
Context

Clorox reported FY2027 Q1 results with 33% sales growth and updated gross margin guidance.

Expected impact

potential upside from sales beat, tempered by margin pressure and guidance downgrade

Evidence & confidence

Sales surged 33% YoY, but gross margin fell to 40.4% and outlook is for 41.5% margin, indicating cost headwinds.

Market effects

Sector

Consumer staples may see broader earnings pressure from input cost inflation.

Regional

U.S. consumer‑goods stocks could react to Clorox's margin outlook.

Global

Limited to U.S. markets; no immediate global ripple.

Counterpoint

What could challenge this read

Margin compression could outweigh sales growth, leading to short pressure.

Key entities

  • company
    Clorox Co.

    U.S. consumer‑goods company reporting FY2027 Q1 results.

Read at source← All news

StoryClorox posts 33% sales growth and EPS beat in Q1 FY2027

Also covered by

5 outlets

Related articles

NOV 2
$CLXHighAI 8/10

Clorox: Fiscal Q1 Earnings Snapshot

Clorox Co. (CLX) reported fiscal Q1 net income of $170M, or $1.39 per share, exceeding analyst expectations of $0.97 per share. Revenue was $1.91B, surpassing forecasts of $1.87B. The company expects full-year earnings of $5.70 to $6 per share.

finance.yahoo.com1 min
NOV 2
$CLXHighAI 8/10

Clorox’s (NYSE:CLX) Q3 CY2026 sales top estimates

Clorox (NYSE:CLX) reported Q3 CY2026 revenue of $1.91B, up 33.3% YoY and 1.5% above estimates. Adjusted EPS of $1.55 beat estimates by 44.6%. Management reiterated full-year EPS guidance of $5.85 at the midpoint. Organic revenue rose 18% YoY. CEO Linda Rendle cited strong execution and timing benefits but noted higher inflationary pressures. Shares rose 2.1% post-results.

finance.yahoo.com2 min
NOV 2
$UPWKMed

Stocks making the biggest moves after hours: Fabrinet, Clorox, Apple, Palantir & more

Upwork shares rose 11% after raising full-year earnings guidance. Palantir's Q3 revenue nearly doubled, surpassing $2B. Lattice Semiconductor's stock jumped 7% on strong Q3 results and raised forecast. Clorox gained 2% with Q1 earnings beating estimates. On Semiconductor fell 2% after announcing a $600M acquisition and Q4 guidance. Apple's Q4 revenue rose 12% to $114.48B, but iPad sales declined. Fabrinet surged 12% on strong Q2 guidance.

cnbc.com2 min
NOV 2
$CLXHighAI 8/10

Clorox tops Q1 estimates despite cost pressures, shares rise

Clorox (CLX) reported Q1 adjusted EPS of $1.55, beating estimates by $0.48, with revenue at $1.91B, up 33% YoY. Shares rose 2%. Growth was driven by the GOJO acquisition and last year's inventory adjustments, but higher costs compressed margins. The company maintained FY2027 guidance, expecting EPS near the low end of the range.

investing.com2 min